Dr. Morris-Rosenfeld is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1100 9th Ave
Seattle, WA 98101Phone+1 206-223-6600
Education & Training
University of Virginia School of MedicineClass of 2013
Certifications & Licensure
WA State Medical License 2019 - 2025
ID State Medical License 2019 - 2019- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Publications & Presentations
PubMed
- Mycophenolate Mofetil Appears Effective for the Treatment of Patients With Refractory Crohn's Disease.Sam Rosenfeld, Kindra Clark-Snustad, Kendra J Kamp, Jeffrey Jacobs, Mitra Barahimi
Crohn's & Colitis 360. 2024-10-01 - 90 citationsB-1b Cells Secrete Atheroprotective IgM and Attenuate AtherosclerosisSam M. Rosenfeld, Heather M. Perry, Ayelet Gonen, Thomas A. Prohaska, Prasad Srikakulapu
Circulation Research. 2015-06-16 - 24 citationsDeletion of bone marrow-derived receptor for advanced glycation end products inhibits atherosclerotic plaque progressionSamuel Morris-Rosenfeld, Erwin Blessing, Michael R. Preusch, Claudia Albrecht, Angelika Bierhaus
European Journal of Clinical Investigation. 2011-11-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
